Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Politics LIVE: Rishi Sunak accused by Keir Starmer at PMQs of ‘prolonging misery’ over strikes and going from ‘clapping to sacking’ nurses

Prime Minister Rishi Sunak was accused by Keir Starmer of choosing to “prolong the misery” over strikes at PMQs.

Evening Standard

Vaccine-Maker CanSino Bio Plans Swiss Listing

The company, which has developed multiple Covid-19 vaccines, aims to tap new international financing and boost its global brand

Caixin Global

Editorial: Delay in making naloxone an over-the-counter drug to counter opioid overdoses was deadly

It's been six years since a startling story in The New York Times detailed how fatal opioid overdoses were tearing through rural regions of the United States "like a plow through soil." The report came as the nation was beginning to grasp that it faced the deadliest wave of drug…

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

IBD Stock Of The Day Medpace Flashes Buy Signal — Why You Should Be Cautious

Medpace Holdings is Tuesday's IBD Stock Of The Day as MEDP stock bounces off its 50-day line amid bullish fourth-quarter expectations.

Investors Business Daily

AstraZeneca Stock Nabs Brief Breakout After $1.8 Billion CinCor Buyout

AstraZeneca stock briefly broke out on Tuesday, a day after announcing its $1.8 billion plan to acquire CinCor.

Investors Business Daily

Rep. Katie Porter seeking Feinstein's Senate seat in 2024

Democratic Rep. Katie Porter of California says she will seek the U.S. Senate seat currently held by Sen. Dianne Feinstein, a fellow Democrat and the oldest member of the chamber

The Independent UK

Illumina's Woes Mount As Guidance Lags And Grail Controversy Continues

Illumina stock plunged to its lowest point in three months Tuesday after the gene-sequencing giant issued a disappointing outlook for 2023.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Pfizer CEO Dismisses Reports of a Paxlovid Generic for China

The U.S. pharmaceutical giant is working on starting domestic production of the branded version of the Covid drug in the first half of this year

Caixin Global

Commentary: Abortion pills in pharmacies are the future. But the FDA should do more to expand access

On Jan. 3, the U.S. Food and Drug Administration took a first step toward making abortion pills available at retail pharmacies. It released new rules outlining how both bricks-and-mortar and mail-order pharmacies can get certified to dispense mifepristone, the first pill in a medication abortion. But the agency also left…

Los Angeles Times

Inside massive Lanarkshire drugs factory run by Glasgow labourer linked to organised crime

Derek Dragnes was jailed at the high court yesterday after police raided an industrial until and uncovered six rooms containing enough equipment and raw materials to manufacture hundreds of thousands of street valium tablets.

Glasgow Live

Full list of medicines affected as Ireland faces major shortages

The Irish public has been warned against stockpiling medication as it could 'disrupt existing stock levels and hamper the supply of medicines for others'

Dublin Live

Full list of 219 medicines there is currently a shortage of - including cough syrups and key antibiotics

Some medicines are not expected to be back in stock for months - with Benylin Dry Coughs Syrup expected to remain off the shelves until April

Irish Mirror

Ireland's pharmacies warn against stockpiling amid severe medicine shortage

Pharmacists are calling on the government to introduce serious shortage protocols, which would enable them to prescribe alternative medicines when others are out of stock

Dublin Live

Sterigenics to pay $408 million to settle hundreds of lawsuits over toxic gas emissions

The company agrees to settle more than 870 suits alleging that its Willowbrook plant released ethylene oxide gas. Last year, a jury awarded a cancer survivor $363 million.

Chicago Sun-Times

Get all your
news in one place.

100’s of premium titles.
One news app.

AAP

Nationwide shortage of common antibiotics

Several antibiotics used to treat infections in children are in short supply, sparking concerns among doctors and pharmacists.

ABC News

Overseas supply issues are causing a shortage of some antibiotics in Australia

Overseas supply issues are leading to a shortage in some antibiotic medications used to treat illnesses such as pneumonia and strep throat.

StockNews.com

3 Must Have Pharma Stocks in January 2023

Rising rates of chronic diseases, an aging population, and increasing healthcare spending should drive the pharma industry’s growth in the upcoming years. Moreover, pharma companies perform steadily regardless of economic conditions due to the inelastic demand for their products. Therefore, it could be wise to invest in fundamentally strong pharma…

Investors Business Daily

IDEXX Laboratories Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating

IDEXX Laboratories sees its Relative Strength Rating reach the 80-plus level.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Man who mass produced ‘street valium’ is jailed for four and a half years

Derek Dragsnes manufactured the drug etizolam at an industrial unit in North Lanarkshire.

StockNews.com

1 Medical Stock to Buy in 2023 and 1 to Avoid

Despite various macroeconomic headwinds, the healthcare industry is well-positioned to cope well due to the inelastic demand for products and services. Moreover, expanding R&D initiatives and favorable government funding should accelerate the industry's growth. Therefore, fundamentally sound medical stocks Premier Inc. (PINC) could be a wise addition to one's portfolio.…

Investors Business Daily

Biotech Giant Regeneron Hit As Eylea Gives Ground To Avastin

Regeneron Pharmaceuticals said sales of its linchpin Eylea drug have been negatively impacted by a short-term shift to rival drug Avastin.

Investors Business Daily

AstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion Deal

AstraZeneca said it has agreed to buy CinCor Pharma, maker of clinical-stage blood pressure drug baxdrostat, in a deal valued at $1.8 billion.

Dublin Live

Pharmacies in short supply on over 200 medications

Pharmacists claim that the shortages have been ongoing for several months and include medications used to treat the Strep A infection, which can cause serious illness amongst young children and elderly adults

Wales Online

Calpol shortage could last for months with other medicines also hit

Industry experts say there could be shortages of other children's medicines

Daily Record

GSK facing months of industrial action as workers go on strike at pharma giant

Electricians, scaffolders, cable pullers and labourers have downed tools in a dispute over bonus payments.

1 … 66 67 68 69

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Regeneron Pharmaceuticals

Medical – Pharmaceuticals

69 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.